Our Science – Gattinoni Website
Luca Gattinoni, M.D.
Selected Publications |
 |
| 1)
Dudda JC, Salaun B, Ji Y, Palmer DC, Monnot GC, Merck E, Boudousquie C, Utzschneider DT, Escobar TM, Perret R, Muljo SA, Hebeisen M, Rufer N, Zehn D, Donda A, Restifo NP, Held W, Gattinoni L, Romero P. MicroRNA-155 Is Required for Effector CD8(+) T Cell Responses to Virus Infection and Cancer. Immunity. 38: 742-53, 2013. [Journal] |
|
| 2)
Lugli E, Dominguez MH, Gattinoni L, Chattopadhyay PK, Bolton DL, Song K, Klatt NR, Brenchley JM, Vaccari M, Gostick E, Price DA, Waldmann TA, Restifo NP, Franchini G, Roederer M. Superior T memory stem cell persistence supports long-lived T cell memory. J. Clin. Invest. 2013. [Journal] |
|
| 3)
Gattinoni L, Restifo NP. Moving T memory stem cells to the clinic. Blood. 121: 567-8, 2013. [Journal] |
|
| 4)
Lugli E, Gattinoni L, Roberto A, Mavilio D, Price DA, Restifo NP, Roederer M. Identification, isolation and in vitro expansion of human and nonhuman primate T stem cell memory cells. Nat Protoc. 8: 33-42, 2013. [Journal] |
|
| 5)
Yang S, Ji Y, Gattinoni L, Zhang L, Yu Z, Restifo NP, Rosenberg SA, Morgan RA. Modulating the differentiation status of ex vivo-cultured anti-tumor T cells using cytokine cocktails. Cancer Immunol. Immunother. 2012. [Journal] |
|
| 6)
Klebanoff CA, Gattinoni L, Restifo NP. Sorting through subsets: which T-cell populations mediate highly effective adoptive immunotherapy?. J. Immunother. 35: 651-60, 2012. [Journal] |
|
| 7)
Gattinoni L, Klebanoff CA, Restifo NP. Paths to stemness: building the ultimate antitumour T cell. Nat. Rev. Cancer. 12: 671-84, 2012. [Journal] |
|
| 8)
Klebanoff CA, Gattinoni L. Stubborn Tregs limit T-cell therapy. Blood. 120: 2352-4, 2012. [Journal] |
|
| 9)
Stroncek DF, Berger C, Cheever MA, Childs RW, Dudley ME, Flynn P, Gattinoni L, Heath JR, Kalos M, Marincola FM, Miller JS, Mostoslavsky G, Powell DJ, Rao M, Restifo NP, Rosenberg SA, O'Shea J, Melief CJ. New directions in cellular therapy of cancer: a summary of the summit on cellular therapy for cancer. J Transl Med. 10: 48, 2012. [Journal] |
|
| 10)
Muranski P, Borman ZA, Kerkar SP, Klebanoff CA, Ji Y, Sanchez-Perez L, Sukumar M, Reger RN, Yu Z, Kern SJ, Roychoudhuri R, Ferreyra GA, Shen W, Durum SK, Feigenbaum L, Palmer DC, Antony PA, Chan CC, Laurence A, Danner RL, Gattinoni L, Restifo NP. Th17 Cells Are Long Lived and Retain a Stem Cell-like Molecular Signature. Immunity. 35: 972-85, 2011. [Journal] |
|
| Click Here to View Expanded Bibliography. |
This page was last updated on 4/23/2013.
